Literature DB >> 6988470

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.

R L Edelson.   

Abstract

Cutaneous T cell lymphoma (CTCL) is a clinically and immunologically defined neoplasm which encompasses epidermotropic (mycosis fungoides, Sézary syndrome) and nonepidermotropic variants. A natural evolution apparently occurs from the epidermotropic to the nonepidermotropic form. In this review, cellular properties of the neoplastic cells are correlated with specific clinical observations, and recent therapeutic advances are discussed. Advances in our understanding of the pathogenesis of CTCL, including preliminary evidence suggesting that keratinocytes may elaborate a hormonal substance capable of inducing T lymphocyte differentiation, are discussed.

Entities:  

Mesh:

Year:  1980        PMID: 6988470     DOI: 10.1016/s0190-9622(80)80385-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  32 in total

1.  Immunotactoid glomerulopathy associated with mycosis fungoides.

Authors:  A Torrelo; M T Rivera; F Mampaso; A España; R Marcèn; J Ortuño; A Ledo
Journal:  Postgrad Med J       Date:  1990-09       Impact factor: 2.401

2.  Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides.

Authors:  K Kaltoft; S Bisballe; T Dyrberg; E Boel; P B Rasmussen; K Thestrup-Pedersen
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

3.  The behavior of epidermotropic lymphoma in twenty-five dogs.

Authors:  B P Wilcock; J A Yager
Journal:  Can Vet J       Date:  1989-09       Impact factor: 1.008

4.  Dermatology-epitomes of progress: new developments in the staging and therapy of mycosis fungoides.

Authors:  N M Price
Journal:  West J Med       Date:  1981-01

5.  Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA.

Authors:  G P Rajan; B Seifert; O Prümmer; H I Joller-Jemelka; G Burg; R Dummer
Journal:  Arch Dermatol Res       Date:  1996-08       Impact factor: 3.017

6.  Ultrastructural morphometric analysis of normal human lymphocytes stimulated in vitro with mitogens and antigens.

Authors:  C M Payne; M J Hicks; A Kim
Journal:  Am J Pathol       Date:  1985-08       Impact factor: 4.307

7.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

Authors:  L M Weiss; G S Crabtree; R V Rouse; R A Warnke
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

8.  Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.

Authors:  S Sano; Y Matsui; S Itami; K Yoshikawa
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.

Authors:  E Ralfkiaer; T A Saati; J Bosq; G Delsol; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

10.  Interleukin-7 is a growth factor for Sézary lymphoma cells.

Authors:  A Dalloul; L Laroche; M Bagot; M D Mossalayi; C Fourcade; D J Thacker; D E Hogge; H Merle-Béral; P Debré; C Schmitt
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.